Department of Gastroenterology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Gastroenterology, Clinical Emergency Hospital of Bucharest, 105402 Bucharest, Romania.
Medicina (Kaunas). 2021 Jan 9;57(1):55. doi: 10.3390/medicina57010055.
Nowadays, humanity faces one of the most serious health crises, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The severity of coronavirus disease 2019 (COVID-19) pandemic is related to the high rate of interhuman transmission of the virus, variability of clinical presentation, and the absence of specific therapeutic methods. COVID-19 can manifest with non-specific symptoms and signs, especially among the elderly. In some cases, the clinical manifestations of hyponatremia may be the first to appear. The pathophysiological mechanisms of hyponatremia among patients with COVID-19 are diverse, including syndrome of inappropriate antidiuretic hormone secretion (SIADH), digestive loss of sodium ions, reduced sodium ion intake or use of diuretic therapy. Hyponatremia may also be considered a negative prognostic factor in patients diagnosed with COVID-19. We need further studies to evaluate the etiology and therapeutic management of hyponatremia in patients with COVID-19.
如今,人类面临着最严重的健康危机之一,即严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)大流行。2019 年冠状病毒病(COVID-19)大流行的严重程度与病毒在人与人之间的高传播率、临床表现的可变性以及缺乏特定治疗方法有关。COVID-19 可能表现出非特异性症状和体征,尤其是在老年人中。在某些情况下,低钠血症的临床表现可能是首先出现的。COVID-19 患者低钠血症的病理生理机制多种多样,包括抗利尿激素分泌不当综合征(SIADH)、钠离子消化丢失、钠离子摄入减少或使用利尿剂治疗。低钠血症也可能被认为是 COVID-19 患者的一个负面预后因素。我们需要进一步的研究来评估 COVID-19 患者低钠血症的病因和治疗管理。